Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marks

Showing results (491-500 of 985) with videos related to

Pageof 99
Sort By:
Annals of the New York Academy of Sciences|January 1, 1988
Cardiorespiratory control during sleepR M Harper, R C Frysinger, J D Marks, et al.
The Review of Scientific Instruments|April 2, 2018
Development of a hybrid molecular beam epitaxy deposition system for in situ surface x-ray studiesTassie K Andersen, Seyoung Cook, Erika Benda, et al.
The Journal of Infectious Diseases|March 4, 2016
Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type HYongfeng Fan, Jason R Barash, Jianlong Lou, et al.
Cancer|June 15, 1989
Intraperitoneal P-32 after negative second-look laparotomy in ovarian carcinomaT R Spencer, R D Marks, J O Fenn, et al.
Gynecologic Oncology|December 11, 1975
Carcinoma of the ovary: the adjunctive use of irradiation A preliminary reportP B Underwood, J O Merritt, M H Lutz, et al.
The Journal of Chemical Physics|February 24, 2020
WIEN2k: An APW+lo program for calculating the properties of solidsPeter Blaha, Karlheinz Schwarz, Fabien Tran, et al.
Investigational New Drugs|May 1, 1991
Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancerJ R Rigas, M G Kris, R J Gralla, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1978
Dysgerminoma--100% control with combined therapy in six consecutive patients with advanced diseaseR D Marks, P B Underwood, H B Othersen, et al.
Gene|March 9, 1996
Identification of functional and structural amino-acid residues by parsimonious mutagenesisR Schier, R F Balint, A McCall, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 8, 2007
Recombinant full-length human IgG1s targeting hormone-refractory prostate cancerBin Liu, Fraser Conrad, Audrey Roth, et al.
Pageof 99

Showing results (491-500 of 985) with videos related to

Sort By:
Pageof 99
Annals of the New York Academy of Sciences|January 1, 1988
Cardiorespiratory control during sleepR M Harper, R C Frysinger, J D Marks, et al.
The Review of Scientific Instruments|April 2, 2018
Development of a hybrid molecular beam epitaxy deposition system for in situ surface x-ray studiesTassie K Andersen, Seyoung Cook, Erika Benda, et al.
The Journal of Infectious Diseases|March 4, 2016
Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type HYongfeng Fan, Jason R Barash, Jianlong Lou, et al.
Cancer|June 15, 1989
Intraperitoneal P-32 after negative second-look laparotomy in ovarian carcinomaT R Spencer, R D Marks, J O Fenn, et al.
Gynecologic Oncology|December 11, 1975
Carcinoma of the ovary: the adjunctive use of irradiation A preliminary reportP B Underwood, J O Merritt, M H Lutz, et al.
The Journal of Chemical Physics|February 24, 2020
WIEN2k: An APW+lo program for calculating the properties of solidsPeter Blaha, Karlheinz Schwarz, Fabien Tran, et al.
Investigational New Drugs|May 1, 1991
Phase II trial of esorubicin (4'deoxydoxorubicin, DxDx) in patients with small cell lung cancerJ R Rigas, M G Kris, R J Gralla, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1978
Dysgerminoma--100% control with combined therapy in six consecutive patients with advanced diseaseR D Marks, P B Underwood, H B Othersen, et al.
Gene|March 9, 1996
Identification of functional and structural amino-acid residues by parsimonious mutagenesisR Schier, R F Balint, A McCall, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 8, 2007
Recombinant full-length human IgG1s targeting hormone-refractory prostate cancerBin Liu, Fraser Conrad, Audrey Roth, et al.
Pageof 99